RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 17 - per page Next page
Order by
Rx and /or OTC dermatology products
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products More
Acquisition of UK Primary Care ethical brands
Strategic divestments of primary care sales focussed brands More
Rx and/or OTC Products for Gastroenterology Market
Seeking new technologies and/or existing products More
Injectables and oral medicines for hospital use
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets More
Seeking innovative oncology, immunology or orphan disease focused prescription based hospital products required for the Portuguese market.
Our Portuguese clients are seeking to in-license prescription based hospital products indicated for the treatment of oncology, immunology and orphan diseases. More
Products for Otorinilaryngology, Pediatrics, Dermatology, Gynecology and Ophthalmology
Products for Otorinilaryngology, Pediatrics, Dermatology, Gynecology and Ophthalmology More
Orally delivered modified release drug delivery systems to overcome first-pass metabolism.
A global OTC drug products group with offices in the UK is seeking orally delivered modified release drug delivery systems that extend the efficacy of active pharmaceutical ingredients (APIs), which are susceptible to a large first-pass metabolism. More
Easy-to-use diagnostic kits to diagnose consumer health related conditions
A global health care group is currently seeking technologies that are able to diagnose health related conditions in consumers. More
Oral dissolving thin film technology with high API loading capabilities
A global OTC healthcare company is currently seeking orally dissolving thin film technologies with capabilities to load high amounts of active pharmaceutical ingredients (APIs) greater than 100mg. More
Long lasting adhesion to mucosa of the upper and lower respiratory tracts
A global OTC Pharma products group is seeking technologies, approaches and materials that are able to prolong adhesion to a mucosal surface of the oral, pharyngeal, throat, nasal and upper & lower respiratory tracts. More
Displaying 1..10 of 17 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients
Jan 2011 - 266 pages - $11,400
R&D Trends: Inflammatory Bowel Disease – Unmet needs fuel diverse pipeline
Sep 2011 - 69 pages - $3,800
R&D Trends: Cystic Fibrosis – New drugs tackle both cause and effect
Oct 2011 - 68 pages - $3,800
Amsterdam Molecular Therapeutics (AMT) Holding N.V. – Product Pipeline Review – H2 2011
Sep 2011 - 59 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us